These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7509531)

  • 1. Proceedings of the 3rd International Conference on Benign Prostatic Hyperplasia, Prostate and Urothelial Cancer. Orlando, Florida, February 25-27, 1993.
    Urology; 1994 Feb; 43(2 Suppl):1-67. PubMed ID: 7509531
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical characteristics of bladder urothelial tumors in male patients--the influences of benign prostatic hyperplasia/benign prostatic enlargement.
    Zhang NZ; Chen J; Ma L; Xu ZS
    Urol Oncol; 2012 Sep; 30(5):646-51. PubMed ID: 20870428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low grade urothelial carcinoma mimicking basal cell hyperplasia and transitional metaplasia in needle prostate biopsy.
    Arista-Nasr J; Martinez-Benitez B; Bornstein-Quevedo L; Aguilar-Ayala E; Aleman-Sanchez CN; Ortiz-Bautista R
    Int Braz J Urol; 2016; 42(2):247-52. PubMed ID: 27256178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The risk of bladder cancer in patients with prostatic hyperplasia and strategies to manage this combination].
    Alyaev YG; Pshikhachev AM; Perekalina AN
    Urologiia; 2016 Nov; (5):115-118. PubMed ID: 28248032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contentious controversies: a report from the 3rd World Congress on Controversies in Urology (February 25-28, 2010, Athens, Greece).
    Rabasseda X
    Drugs Today (Barc); 2010 Apr; 46(4):291-6. PubMed ID: 20502726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Errors in the diagnosis of benign prostatic hyperplasia].
    Panchev P; Kumanov Kh; Kirilov S; Ormanov I; Filev A; Ianev K
    Khirurgiia (Sofiia); 1997; 50(3):23-4. PubMed ID: 9739837
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: relevance to prostate cancer and benign hyperplasia.
    Zeng Y; Kakehi Y; Nouh MA; Tsunemori H; Sugimoto M; Wu XX
    Prostate; 2009 Feb; 69(3):283-92. PubMed ID: 19025891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention.
    Nickel JC; Roehrborn CG; Castro-Santamaria R; Freedland SJ; Moreira DM
    J Urol; 2016 Nov; 196(5):1493-1498. PubMed ID: 27378134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic artery embolization to treat lower urinary tract symptoms related to benign prostatic hyperplasia and bleeding in patients with prostate cancer: proceedings from a multidisciplinary research consensus panel.
    Golzarian J; Antunes AA; Bilhim T; Carnevale FC; Konety B; McVary KT; Parsons JK; Pisco JM; Siegel DN; Spies J; Wasserman N; Gowda N; Ahrar K
    J Vasc Interv Radiol; 2014 May; 25(5):665-74. PubMed ID: 24560898
    [No Abstract]   [Full Text] [Related]  

  • 11. [Choosing treatment for patients with bladder cancer combined with prostatic hyperplasia].
    Glybochko PV; Alyaev YG; Pshikhachev AM; Sorokin NI; Dymov AM
    Urologiia; 2016 Nov; (5):92-96. PubMed ID: 28248027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens.
    Bruins HM; Djaladat H; Ahmadi H; Sherrod A; Cai J; Miranda G; Skinner EC; Daneshmand S
    J Urol; 2013 Nov; 190(5):1704-9. PubMed ID: 23707451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [THE VALUE OF THE THROMBODYNAMOGRAM IN PROSTATIC ADENOMA AND PROSTATIC AND BLADDER NEOPLASMS].
    DEBIASI R
    J Urol Nephrol (Paris); 1965 Jun; 71():407-12. PubMed ID: 14322124
    [No Abstract]   [Full Text] [Related]  

  • 14. Resistive index of prostate capsular arteries: a newly identified parameter to diagnose and assess bladder outlet obstruction in patients with benign prostatic hyperplasia.
    Zhang X; Li G; Wei X; Mo X; Hu L; Zha Y; Hou J
    J Urol; 2012 Sep; 188(3):881-7. PubMed ID: 22819411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [One-stage transurethral resection of the urinary bladder and the prostate in patients with superficial cancer of the urinary bladder combined with benign prostatic hyperplasia].
    Karaguzhin SG; Merinov DS; Martov AG
    Urologiia; 2005; (5):17-21. PubMed ID: 16281833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
    J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and validation of the core lower urinary tract symptom score as an outcome assessment tool for the treatment of benign prostatic hyperplasia: effects of the α1-adrenoreceptor antagonist silodosin.
    Ito H; Sano F; Ogawa T; Yao M
    Int J Urol; 2014 Jan; 21(1):108-12. PubMed ID: 23662900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of COX-2 in prostatic cancer and benign prostatic hyperplasia].
    Zang T; Sun F; Li Y
    Zhonghua Wai Ke Za Zhi; 2001 Sep; 39(9):702-3. PubMed ID: 11769607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme insertion/deletion and angiotensin type 1 receptor A1166C polymorphisms as genetic risk factors in benign prostatic hyperplasia and prostate cancer.
    Sierra Díaz E; Sánchez Corona J; Rosales Gómez RC; Gutierrez Rubio SA; Vázquez Camacho JG; Solano Moreno H; Morán Moguel MC
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):241-6. PubMed ID: 20026870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk of treatment for benign prostatic hyperplasia in Japanese men: a 15-year longitudinal community-based study.
    Fukuta F; Masumori N; Mori M; Tsukamoto T
    Int J Urol; 2013 Jan; 20(1):100-6. PubMed ID: 23106204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.